跳至主要内容
临床试验/NCT06730360
NCT06730360招募中不适用

Clinical and Radiographic Assessment of Photobiomodulated MTA Pulpotomy in Immature First Permanent Molars with Irreversible Pulpitis: a Randomized Controlled Clinical Trial

Mansoura University1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2024年10月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
72
试验地点
1
主要终点
Clinical Success of Pulpotomy Treatment

研究概览

简要总结

This study evaluates the effectiveness of photobiomodulation (PBM) in conjunction with mineral trioxide aggregate (MTA) pulpotomy for treating irreversible pulpitis in immature first permanent molars. PBM, also known as low-level laser therapy (LLLT), is used to enhance healing, reduce inflammation, and manage pain in young teeth. The randomized clinical trial involves 72 children aged 6-9 years, divided into two groups: one receiving MTA pulpotomy alone and the other receiving MTA pulpotomy with PBM. Clinical and radiographic outcomes will be assessed at intervals over 15 months. This research aims to determine the combined therapy's efficacy in improving pulp healing and reducing post-operative discomfort compared to MTA alone.

详细描述

This randomized controlled trial evaluates the clinical and radiographic outcomes of MTA pulpotomy, with and without PBM, for immature permanent molars diagnosed with irreversible pulpitis. The study includes two parallel groups of 36 children each. Group I will undergo MTA pulpotomy alone, while Group II will receive PBM treatment alongside MTA pulpotomy.

PBM employs low-level laser therapy to stimulate pulp tissue regeneration, enhance mitochondrial activity, and reduce inflammation and pain, thereby potentially improving MTA pulpotomy outcomes. Key inclusion criteria involve children with deep carious lesions and clinical signs of irreversible pulpitis but without pulpal necrosis. Follow-up will occur at 3, 6, 12, and 15 months post-treatment to evaluate success based on the absence of clinical symptoms (e.g., pain, tenderness) and radiographic indicators of healing.

By comparing these two approaches, the study aims to provide insights into PBM's role as an adjunctive therapy for vital pulp preservation, particularly in pediatric dentistry.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
6 Years 至 9 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Children aged 6 to 9 years.
  • •Non-contributory medical history (healthy otherwise).
  • •Presence of carious first permanent molars with the following characteristics:
  • •Deep caries extending to ≥2/3 of dentin.
  • •Positive response to cold testing.
  • •Clinical diagnosis of irreversible pulpitis (moderate or severe), with or without periapical periodontitis.
  • •Restorable tooth.
  • •Probing pocket depth and mobility within normal limits.
  • •No signs of pulpal necrosis, including sinus tract or swelling.

排除标准

  • •Insufficient bleeding after pulp exposure (indicating necrotic or partially necrotic pulp).
  • •Presence of systemic or medical conditions that may contraindicate participation.
  • •Teeth with unrestorable structure.
  • •Teeth showing signs of pulpal necrosis, such as the presence of a sinus tract or swelling.

研究组 & 干预措施

MTA Pulpotomy without Photobiomodulation

Active Comparator

Participants will receive MTA (Mineral Trioxide Aggregate) pulpotomy as a standard treatment without the application of photobiomodulation (low-level laser therapy).

干预措施: MTA Pulpotomy without photobiomodulation (Procedure)

MTA Pulpotomy with Photobiomodulation

Experimental

Participants will receive MTA (Mineral Trioxide Aggregate) pulpotomy treatment enhanced with photobiomodulation (low-level laser therapy). The laser will be applied to pulp stumps before the placement of MTA to promote healing and reduce inflammation.

These entries should resolve the error and align with your protocol.

干预措施: MTA Pulpotomy with Photobiomodulation (LLLT) (Procedure)

结局指标

主要结局

Clinical Success of Pulpotomy Treatment

时间窗: 15 months post-treatment (assessed at 3, 6, 12, and 15 months).

Evaluation of clinical signs and symptoms (absence of pain, tenderness to percussion, sinus tract, or swelling). Treatment is considered successful if these are absent at all follow-up visits.

次要结局

  • Radiographic Healing(15 months post-treatment (assessed at 6, 12, and 15 months).)
  • Root Development Progression(15 months post-treatment (assessed at 6, 12, and 15 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Peter Samir

assistant lecturer

Mansoura University

研究点 (1)

Loading locations...

相似试验